Posted by David Bergstrom on November 15, 2001 at 11:21:02:
Bristol Myers was guilty of "off-labeling" Stadol NS which means that they petitioned the FDA for non-control of Stadol NS for use as a post operative acute medication and then marketed it as a miracle cure for migraines that could be taken up to 18 times a day at 30 minute intervals without repercussions knowing full well that migraine sufferers have reoccuring attacks requiring repeat usage. Not what they told the FDA the drug was intended to be used. Curious as to any members problems with this drug.
Post a Followup